Eli Lilly and Company

CDI – Délégué(e) Médical(e) Diabétologie – Ile de France Nord - F/H

Paris, Île-de-France, France

Not SpecifiedCompensation
Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

Candidates should possess a medical degree and be licensed to practice medicine in France, demonstrating a strong understanding of diabetes and its associated patient care pathways.

Responsibilities

The Medical Delegate will provide pharmaceutical information to healthcare professionals adhering to ethical guidelines and product information leaflets (AMM), serve as an expert in patient care pathways, therapeutic areas, and products, propose options for improved patient management through listening and trust, manage their territory and collaborate internally and externally to build strong partnerships, achieve goals within the framework of pharmaceutical regulations, engage with healthcare professionals, regularly update knowledge of products and regulations, prepare visits by focusing on healthcare professional needs, collect and transmit requests and information, identify and utilize preferred communication channels, embody Team Lilly and collaborate transversally with Lilly teams to create a positive customer experience, and organize and conduct professional communication activities.

Skills

Pharmaceutical information
Healthcare professional engagement
Patient care pathways
Therapeutic areas
Product knowledge
Regulatory compliance
Territory management
Partnership building
Communication channels
Medical visit tools
Pharmacovigilance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI